Note: Ingredients listed on restricted chemical lists
EC/CAS
202-316-6/94-24-6
Name of the chemical
Tetracaine (INN) and its salts
Concentration
<=100%
General Information
Version
6.6
Revision date
2023-11-02
Product name
TETRACAINE, UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
CAS No.
94-24-6
REACH No
A
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H317
Hazard statements
Code
Statements
H301
Toxic if swallowed
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 Toxic if swallowed. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer.
Precautionary statements
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P330 + P331 + IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P310 Immediately call a POISON CENTER/ doctor.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 3), H301 Skin sensitization (Category 1), H317 Carcinogenicity (Category 2), H351 For the full text of the H-Statements mentioned in this Section, see Section 16.